Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

Neurology

Volumn 54, Issue 6, 2000, Pages 1344-1349

  Ernst, Thomas ^a   Chang, Linda ^a   Leonido Yee, Maria ^a   Speck, Oliver ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Brain; Magnetic resonance spectroscopy; Metabolism; Methamphetamine; MRI; Neuronal loss

Indexed keywords

CHOLINE DERIVATIVE; CREATINE; DRUG METABOLITE; INOSITOL; METHAMPHETAMINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG ABUSE; DRUG BRAIN LEVEL; FEMALE; GRAY MATTER; HUMAN; MALE; NEUROTOXICITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEROTONINERGIC NERVE CELL; WHITE MATTER;

EID: 0034724360     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.6.1344     Document Type: Article

References (43)

1. Office of Applied Studies. Preliminary results from the 1996 National Household Survey on Drug Abuse. : Substance Abuse and Mental Health Services Administration, 1996.
2. Drug Abuse Warning Network. Year-end preliminary estimates from the 1996 Drug Abuse Warning Network. : Substance Abuse and Mental Health Services Administration, 1996.
3. Chung CK, Simon SL, Kenan JN, Rawson R, Ling W. Comorbidity in drug-related admissions to a psychiatric emergency room. College on Problems of Drug Dependence, sixth annual scientific meeting. Scottsdale, AZ: 1998:22.
4. Volkow ND, Wang GJ, Fischman MW, et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997;386:827-830.
5. Wang AM, Soujanen JN, Colucci VM, Rumbaugh CL, Hollenberg NK. Cocaine- and methamphetamine-induced acute cerebral vasospasm: an angiographic study in rabbits. AJNR Am J Neuroradiol 1990;11:1141-1146.
6. Cook CE, Jeffcoat AR, Hill JM, et al. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-( + ) -methamphetamine hydrochloride. Drug Metab Dispos 1993;21:717-723.
7. Yu YJ, Cooper DR, Wellenstein DE, Block B. Cerebral angiitis and intracerebral hemorrhage associated with methamphetamine abuse: case report. J Neurosurg 1983;58:109-111.
8. Kramer JC, Fischman VS, Littlefield DC. Amphetamine abuse: pattern and effects of high doses taken intravenously. JAMA 1967;201:305-309.
9. Bell DS. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 1973;29:35-40.
10. Murray JB. Psychophysiological aspect of amphetamine-methamphetamine abuse. J Psychol 1998;132:227-237.
11. Griffith JD, Cavanaugh J, Oates J. Schizophreniform psychosis induced by large-dose administration of D-amphetamine. J Psychedel Drugs 1969;2:42-48.
12. Smith DE, Fischer CM. Acute amphetamine toxicity. J Psychedel Drugs 1969;2:49-54.
13. Sato M. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann NY Acad Sci 1992;654:160-170.
14. Iwanami A, Sugiyama A, Kuroki N, et al. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. Acta Psychiatr Scand 1994;89:428-432.
15. Woolverton WL, Ricaurte GA, Forno LS, Seiden LS. Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res 1989;486:73-78.
16. Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR Seiden LS. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 1987;241:338-345.
17. Wagner GC, Ricaurte GA, Johanson CE, Schuster CR, Seiden LS. Amphetamine induces depletion of dopamme and loss of dopamine uptake sites in caudate. Neurology 1980;30:547-550.
18. Hess A, Desiderio C, McAuliffe WG. Acute neuropathological changes in the caudate nucleus caused by MPTP and methamphetamine: immunohistochemical studies. J Neurocytol 1990;19:338-342.
19. Pu C, Vorhees CV. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Brain Res Dev Brain Res 1993;72:325-328.
20. Linder JC, Young SJ, Groves PM. Electron microscopic evidence for neurotoxicity in the basal ganglia. Neurochem Int 1995;26:195-202.
21. McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users, evidence from positron emission tomography. J Neurosci 1998; 18:8417-8422.
22. Volkow N, Chang L, Wang G, et al. Evidence in humans that methamphetamine abuse produces long lasting changes in dopamine transporters. Presented at the Society of Nuclear Medicine Meeting. Los Angeles, CA. 1999.
23. Bottomley PA. Spatial localization in NMR spectroscopy in vivo Ann NY Acad Sci 1987;508:333-348.
24. 1H MR spectroscopy of the frontal lobe. Magn Reson Med 1996;36:462-468.
25. Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain. I: compartments and water. J Magn Reson 1993;B102:1-8.
26. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II: metabolite concentrations. J Magn Reson 1993;B102:9-19.
27. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989.
28. Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Haenicke W, Sauter R. Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy. Magn Reson Med 1989;9:126-131.
29. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752.
30. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303-324.
31. Breiter SN, Arroyo S, Mathews VP, Lesser RP, Bryan RN, Barker PB. Proton MR spectroscopy in patients with seizure disorders. AJNR Am J Neuroradiol 1994;15:373-384.
32. Ende GR, Laxer KD, Knowlton RC, et al. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology 1997;202:809-817.
33. Moats R, Ernst T, Shonk T, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimers disease. Magn Reson Med 1994;32:110-115.
34. Ernst T, Chang L, Melchor R, Mehringer CM. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 1997;203:829-836.
35. Chang L, Miller BL, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995;197: 527-531.
36. Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E. Cerebral metabolites correlate with clinical severity of HIV-cognitive motor complex. Neurology 1999;52:100-108.
37. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:289-298.
38. Pu C, Broening HW, Vorhees CV. Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex. Synapse 1996;23:328-334.
39. Chang L, Ernst T, Tornatore C, et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 1997;48:836-845.
40. Bruhn H, Frahm J, Merboldt KD, et al. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 1992;32:140-150.
41. Bradley C. The behavior of children receiving Benzedrine. Am J Othopsychiatry 1937;94:577-585.
42. Findling RL, Dogin JW. Psychopharmacology of ADHD: children and adolescents. J Clin Psychiatry 1998;59:42-49.
43. Mitler MM, Hajdukovic R, Erman MK. Treatment of narcolepsy with methamphetamine. Sleep 1993;16:306-317.